tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Revenue

Compare
839 Followers

Immunovant Revenue

Immunovant had a revenue of 160.00K in the quarter ending Mar 31, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 160.00K, Increased -89.33%. In the fiscal year ending Mar 31, 2025, Immunovant had annual revenue of 0.00 with ― growth.
Revenue (ttm)
160.00K
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
362
Market Cap
$2.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
0.00
Mar 31, 2024
0.00
Mar 31, 2023
0.00
Mar 31, 2022
0.00
Mar 31, 2021
0.00
Mar 31, 2020
0.00
Mar 31, 2019
0.00
Mar 31, 2018
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis